PIEPER STEVEN (Chief Financial Officer) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2022ACC: 0001867096-22-000012
Officer· Chief Financial Officer
Since Oct 2021
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
105.9%
1/3/2022
188.83K→388.83K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2022 | A · Award | +200K | — | — | 105.9% | 188.83K | 388.83K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported